I'm pretty sure that's in "definitely not" territory. I would expect that initial funding to go towards productizing the actual blood tests -- I'm assuming they

I'm pretty sure that's in "definitely not" territory. I would expect that initial funding to go towards productizing the actual blood tests -- I'm assuming they're at more or less proof-of-concept level at this point. That would be enough to get some sales to individual offices without large records systems and maybe even some overseas and doctors-without-borders types. I would expect larger rounds of follow-on funding to enable those larger integrations, which would then open up the large practices and hospitals. Also, more pessimistically, I don't think less than $4m is even enough to start courting all the admins that would need to be greased to get large hospital sales, even if all the tech existed...